@hswapnil @hagilani @medrants@gchertow@kidney_boy It's important to appreciate that we were not treating hyperphosphatemia- we were treating advanced chronic kidney disease. I totally agree we need to treat patients, not just their lab values. Does anyone think our current SOC is adequate/optimal in advanced CKD?
Post-dialysis fatigue is prevalent and incapacitating. New research from Stanford Nephrology Fellow Dr Vishal Duggal @vishalduggal investigates the effect of lowering blood flow in #hemodialysis in addressing this issue
https://t.co/uwBNEOAtzI
What are the benefits of knowing the genetic diagnosis in your patients? In my population the benefits still dont justify the cost of testing in all patients. Hoping it to come down #NephJC